Speaking as a guy in medical devices, I would love for a YC-like organization to exist for my industry, though I think the structure of any such organization would be quite different than what PG & Co. do now.
Just three examples: First, the capital requirements of a med dev company are much higher than a software company. 11K + 3K*n wouldn't even cover the early biocompatibility and animal trials needed to demonstrate proof of concept.
Second, there is less measurable progress in 10 weeks relative to a software company, due in part to the length of the aforementioned trials.
Third, there's no ability to release a minimum viable product to customers and quickly pivot based on their feedback. That's partly because in medical technology 'customer' is an unclear concept and partly because your product won't get used in a meaningful way until feasibility human trials, which are at minimum several months after prototypes are created.
Just three examples: First, the capital requirements of a med dev company are much higher than a software company. 11K + 3K*n wouldn't even cover the early biocompatibility and animal trials needed to demonstrate proof of concept.
Second, there is less measurable progress in 10 weeks relative to a software company, due in part to the length of the aforementioned trials.
Third, there's no ability to release a minimum viable product to customers and quickly pivot based on their feedback. That's partly because in medical technology 'customer' is an unclear concept and partly because your product won't get used in a meaningful way until feasibility human trials, which are at minimum several months after prototypes are created.